<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-2014-28-8-2</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-28-8-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Seizure Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Comparison of 5- and 30-Minute Status Epilepticus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0798-0131</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>John J.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Ann &#x0026; Robert H. Lurie Children&#x0027;s Hospital of Chicago, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1">
<label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>08</month>
<year>2014</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>31</day>
<month>10</month>
<year>2015</year>
</pub-date>
<volume>28</volume>
<issue>8</issue>
<fpage>58</fpage>
<lpage>58</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2014 The Author(s)</copyright-statement>
<copyright-year>2014</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/j.yebeh.2014.05.018" vol="37C" page="1">
<article-title>Comparison of pediatric patients with status epilepticus lasting 5-29 min versus &#x003E;30 min</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Investigators at Boston Children&#x0027;s Hospital and other centers compared the characteristics of patients with status epilepticus (SE) lasting 5-29 min with those with SE lasting &#x003E;30 min.</p>
</abstract>
<kwd-group>
<kwd>Status Epilepticus</kwd>
<kwd>Developmental Delay</kwd>
<kwd>EEG Abnormalities</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Investigators at Boston Children&#x0027;s Hospital and other centers compared the characteristics of patients with status epilepticus (SE) lasting 5-29 min with those with SE lasting &#x003E;30 min. Of a total 445 patients with a median age at SE of 5.5 (2.8-10.5) years, 296 (66.5%) had SE lasting 5-29 min, and in 149 (33.5%) SE lasted &#x003E;30 min. Patients with SE &#x003E;30 min were younger than those with SE 5-29 min at time of seizure onset (median 1 vs 2.1 years, p = 0.0007). SE as the first seizure presentation was more frequent in patients with SE &#x003E;30 min (24.2% vs 12.2%, p = 0.002). MRI abnormalities tended to be more frequent in patients with SE &#x003E;30 min (70.5% vs 57.1%, p = 0.061). Shorter vs longer SE cases showed no differences in seizure frequency, seizure types (febrile vs nonfebrile), developmental delay, and EEG abnormalities at baseline. At a median follow-up of 3.7 years after SE, 21 patients (4.7%) had died (median time of 3.1 years after SE), mostly unrelated to epilepsy. The odds of dying showed an increase of 0.005 per min of SE duration. SE thresholds of either 5 or 30 min identify groups of patient with similar electroclinical characteristics. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENTARY. Longer SE duration (&#x003E;30 min) probably reflects a more severe underlying cause for SE, but patients with shorter (5-29 min) SE have comparable electroclinical characteristics to those with longer SE duration. Since seizures are more difficult to treat and carry a poorer outcome the longer they last [<xref ref-type="bibr" rid="CIT0002">2</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>], seizures lasting 5 min or longer are treated as aggressively as those &#x003E; 30 min duration. Seizures (5-29 min) are considered as &#x201C;impending&#x201D; SE and those &#x003E; 30 min as &#x201C;established&#x201D; SE.</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iv&#x00E1;n S&#x00E1;nchez</surname>
<given-names>Fern&#x00E1;ndez</given-names>
</name>
<name>
<surname>Martina</surname>
<given-names>Vendrame</given-names>
</name>
<name>
<surname>Kush</surname>
<given-names>Kapur</given-names>
</name>
<name>
<surname>Jacqueline</surname>
<given-names>Klehm</given-names>
</name>
<name>
<surname>Serife</surname>
<given-names>Uysal</given-names>
</name>
<name>
<surname>Mustafa</surname>
<given-names>Gedik</given-names>
</name>
</person-group>
<article-title>Comparison of pediatric patients with status epilepticus lasting 5-29 min versus &#x003E;30 min</article-title>
<source>Epilepsy Behav</source>
<year>2014</year>
<month>Jun</month>
<volume>37C</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/j.yebeh.2014.05.018</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eriksson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mets&#x00E4;ranta</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Huhtala</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Auvinen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kuusela</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Koivikko</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Treatment delay and the risk of prolonged status epilepticus</article-title>
<source>Neurology</source>
<year>2005</year>
<month>Oct</month>
<day>25</day>
<volume>65</volume>
<issue>8</issue>
<fpage>1316</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000180959.31355.92</pub-id>
<pub-id pub-id-type="pmid">16247069</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seinfeld</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shinnar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hesdorffer</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shinnar</surname>
<given-names>RC</given-names>
</name>
<etal/>
</person-group>
<article-title>Emergency management of febrile status epilepticus: results of the FEBSTAT study</article-title>
<source>Epilepsia</source>
<year>2014</year>
<month>Mar</month>
<volume>55</volume>
<issue>3</issue>
<fpage>388</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1111/epi.12526</pub-id>
<pub-id pub-id-type="pmid">24502379</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>